Boxer Capital, LLC’s Regeneron Pharmaceuticals Position
Does Boxer Capital, LLC own Regeneron Pharmaceuticals (REGN)? Not currently — the last reported position was 135.0K shares worth $66M in Q1 2020; the fund’s latest 13F (Q4 2024) no longer reports it.
Position Value
$66M
Q1 2020
Shares
135.0K
% of Portfolio
+4.49%
Quarters Held
1
position exited
Position History REGN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2020 | 135.0K | $66M | +4.49% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of REGN.